Skip to content

Clinical trials

Alzheimer Disease trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Country / region: Netherlands Clear all

132 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20031
20041
20053
20064
20073
20082
20097
20102
20113
20127
20134
20147
201510
20163
20176
20187
20196
20208
20218
202211
20235
20248
202511
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed68
Terminated30
Recruiting15
Active, not recruiting8
Unknown status8
Suspended2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche8
Janssen Research & Development, LLC8
Pfizer6
Maastricht University Medical Center5
Novartis Pharmaceuticals5
Radboud University Medical Center5
Washington University School of Medicine5
University Medical Center Groningen4
GlaxoSmithKline3
Sanofi3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease132
Dementia32
Cognitive Dysfunction17
Neurodegenerative Diseases8
Brain Diseases6
Amyloid Neuropathies, Familial4
Amyloidosis4
Central Nervous System Diseases4
Mental Disorders3
Nervous System Diseases3

Trials

Showing 26 to 50 of 132. Each trial links to its page on Pharma Observatory.

32 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.